Pegylated Interferon alpha 2-b

Medical Advocates
Pegylated Interferon Alfa-2b (PEG-INTRON)

HIV/HCV Conference Citations

XVII International AIDS Conference
15th CROI
13th CROI
XV International AIDS Conference
3rd IAS Conference
11th CROI

Peg Inf Alfa-2b HIV/HCV Main Page Main New/Newsworthy Home Page

Last Update: October 22, 2008
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

XVII Iinternational AIDS Conference

Efficacy of the treatment with peginterferon alfa-2a or peginterferon alfa-2b in co-infected patients treated at
the reference center for AIDS in Santos, SP, Brazil
M. Caseiro, S.O. Costa, M.H. Ventura, et al
Abstract

13th CROI

Sustained Virologic Response (SVR) in HIV-HCV Co-infected Patients with HCV Genotype 1(G1)
Infection who have a Rapid Virological Response (RVR) at Week 4 of Treatment with Peginterferon
Alfa-2a (40KD) (PEG IFNa-2a, PEGASYSŽ) Plus Ribavirin (RBV, COPEGUSŽ): AIDS PEGASYS
Ribavirin International Co-infection Trial (APRICOT)
D Dieterich, F Duff, M Sulkowski, et al
Abstract
POSTER
Predictive Value of Early Virological Response to Treatment with Interferon-base Regimens
Plus Ribavirin in HIV Patients with Chronic Hepatitis C
M Laguno, M Larrousse, J Murillas, et al
PDF Poster Abstract

3rd IAS Conference

Early hepatitis C viral kinetics prediction of SVR In HIV/Hcv co-infected patients
treated with pegylated interferon-alpha 2B (PEG-LFN) and ribavirin (RBV)
Neumann A., Wu L., McLaughlin M., Koratich C., et al
Abstract

XV Iinternational AIDS Conference

Interferon α 2b and ribavirin in the treatment of patients with chronic viral hepatitis C
coinfected with HIV preliminary report
E Mularska, M Beniowski, E Janczewska-Kazek, et al
Abstract
Final Results of ANRS HC02-RIBAVIC: A Randomized Controlled Trial of Pegylated-
Interferon-alfa-2b plus Ribavirin vs Interferon-alfa-2b plus Ribavirin for the Initial
Treatment of Chronic Hepatitis C in HIV Co-infected Patients
C Perronne, F Carrat, F Bani-Sadr, et al
Abstract

11th CROI

HCV Resistance to Peg-Interferon/Ribavirin Therapy Is Associated with Increased
Immune Activation in HIV/HCV Co-infected Patients
RA Lempicki, J Yang, G Dennis, et al
(Abstract

Peg Inf Alfa-2b HIV/HCV Main Page Main New/Newsworthy Home Page

Peginterferon Afa-2b HIV/HCV Indications